Association of Pretreatment Anemia with Pathological Response and Survival of Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Population-Based Study-Reference-Cited by-同舟云学术

Association of Pretreatment Anemia with Pathological Response and Survival of Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Population-Based Study

Published:2015-08-20 Issue:8 Volume:10 Page:e0136268
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Zhu Wenjie,Xu Binghe

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference30 articles.

1. Prevalence and outcomes of anemia in cancer: a systematic review of the literature;K Knight;Am J Med,2004

2. Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review;JJ Caro;Cancer,2001

3. Prognostic impact of haemoglobin levels in breast cancer;DU Boehm;Anticancer Res,2007

4. Impact of preoperative anemia on relapse and survival in breast cancer patients;Y Zhang;BMC Cancer,2014

5. Treatment resistance of solid tumors: role of hypoxia and anemia;P Vaupel;Med Oncol,2001

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Importance of Hypoxia-Related to Hemoglobin Concentration in Breast Cancer;Cell Biochemistry and Biophysics;2024-07-03

2. Association between the Khorana risk score and all-cause mortality in Japanese patients with gastric and colorectal cancer: A retrospective cohort study;World Journal of Gastrointestinal Oncology;2023-10-15

3. [18F]FDG PET/CT for predicting triple-negative breast cancer outcomes after neoadjuvant chemotherapy with or without pembrolizumab;European Journal of Nuclear Medicine and Molecular Imaging;2023-08-22

4. Incidence of anemia and red blood cell (RBC) transfusion requirement in breast cancer;CASP J INTERN MED;2023

5. Hematological abnormalities before and after initiation of cancer treatment among breast cancer patients attending at the University of Gondar comprehensive specialized hospital cancer treatment center;PLOS ONE;2022-08-08